These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 16113424

  • 1. Reducing the frequency and severity of exacerbations of chronic obstructive pulmonary disease.
    Calverley PM.
    Proc Am Thorac Soc; 2004; 1(2):121-4. PubMed ID: 16113424
    [Abstract] [Full Text] [Related]

  • 2. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 3. [Combination of inhaled salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial].
    Fang LZ, Liang X, Zhang JQ, Liu L, Fu WP, Zhao ZH, Dai LM.
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):811-4. PubMed ID: 19080533
    [Abstract] [Full Text] [Related]

  • 4. Similarities and differences in asthma and chronic obstructive pulmonary disease exacerbations.
    Pauwels RA.
    Proc Am Thorac Soc; 2004 Nov; 1(2):73-6. PubMed ID: 16113416
    [Abstract] [Full Text] [Related]

  • 5. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA, Donohue JF.
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [Abstract] [Full Text] [Related]

  • 6. [Pneumology. Inhaled corticosteroids in COPD: more and interesting data!].
    Rochat T.
    Rev Med Suisse; 2008 Jan 16; 4(140):155-7. PubMed ID: 18309880
    [Abstract] [Full Text] [Related]

  • 7. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug 16; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 8. Contemporary management of chronic obstructive pulmonary disease: scientific review.
    Sin DD, McAlister FA, Man SF, Anthonisen NR.
    JAMA; 2003 Nov 05; 290(17):2301-12. PubMed ID: 14600189
    [Abstract] [Full Text] [Related]

  • 9. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF.
    Ned Tijdschr Geneeskd; 2007 Oct 06; 151(40):2195-7. PubMed ID: 17969568
    [Abstract] [Full Text] [Related]

  • 10. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP.
    Am J Med; 2006 Oct 06; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [Abstract] [Full Text] [Related]

  • 11. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.
    Tashkin DP.
    Expert Rev Respir Med; 2010 Jun 06; 4(3):279-89. PubMed ID: 20524910
    [Abstract] [Full Text] [Related]

  • 12. The role of corticosteroids in chronic obstructive pulmonary disease.
    Calverley PM.
    Semin Respir Crit Care Med; 2005 Apr 06; 26(2):235-45. PubMed ID: 16088440
    [Abstract] [Full Text] [Related]

  • 13. Tiotropium versus salmeterol for the prevention of exacerbations of COPD.
    Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken MP, Beeh KM, Rabe KF, Fabbri LM, POET-COPD Investigators.
    N Engl J Med; 2011 Mar 24; 364(12):1093-1103. PubMed ID: 21428765
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Inhaled corticosteroid/beta-2 agonist therapy in moderate COPD].
    Yıldırım N.
    Tuberk Toraks; 2010 Mar 24; 58(2):192-201. PubMed ID: 20865575
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
    Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J, TORCH investigators.
    N Engl J Med; 2007 Feb 22; 356(8):775-89. PubMed ID: 17314337
    [Abstract] [Full Text] [Related]

  • 18. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM, Bollmeier SG, Finnegan PM.
    Ann Pharmacother; 2008 Dec 22; 42(12):1832-42. PubMed ID: 18957624
    [Abstract] [Full Text] [Related]

  • 19. Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology.
    Seemungal T, Stockley R, Calverley P, Hagan G, Wedzicha JA.
    COPD; 2007 Sep 22; 4(3):177-83. PubMed ID: 17729060
    [Abstract] [Full Text] [Related]

  • 20. Pharmacotherapy for mortality reduction in chronic obstructive pulmonary disease.
    Sin DD, Man SF.
    Proc Am Thorac Soc; 2006 Sep 22; 3(7):624-9. PubMed ID: 16963545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.